0000899243-15-003144.txt : 20150814
0000899243-15-003144.hdr.sgml : 20150814
20150814160530
ACCESSION NUMBER: 0000899243-15-003144
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150814
DATE AS OF CHANGE: 20150814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001273636
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 593553710
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 11801 RESEARCH DRIVE
STREET 2: SUITE D
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: 386-462-2204
MAIL ADDRESS:
STREET 1: 11801 RESEARCH DRIVE
STREET 2: SUITE D
CITY: ALACHUA
STATE: FL
ZIP: 32615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chulay Jeffrey D.
CENTRAL INDEX KEY: 0001598537
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36370
FILM NUMBER: 151055686
MAIL ADDRESS:
STREET 1: C/O APPLIED GENETIC TECHNOLOGIES CORP.
STREET 2: 11801 RESEARCH DRIVE, SUITE D
CITY: ALACHUA
STATE: FL
ZIP: 32615
5
1
doc5.xml
FORM 5 SUBMISSION
X0306
5
2015-06-30
0
0
1
0001273636
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
0001598537
Chulay Jeffrey D.
C/O APPLIED GENETIC TECHNOLOGIES CORP.
11801 RESEARCH DRIVE, SUITE D
ALACHUA
FL
32615
0
1
0
0
VP and Chief Medical Officer
Common Stock
2014-11-13
4
M
0
2277
3.50
A
7277
D
Common Stock
2015-01-29
4
M
0
2500
0.35
A
7277
D
Common Stock
2015-03-09
4
M
0
2500
0.35
A
7277
D
Stock Option (Right to Buy)
3.50
2014-11-13
4
M
0
2277
0.00
D
2017-05-31
Common Stock
10305
8028
D
Stock Option (Right to Buy)
0.35
2015-01-29
4
M
0
2500
0.00
D
2023-01-06
Common Stock
35511
30511
D
Stock Option (Right to Buy)
0.35
2015-03-09
4
M
0
2500
0.00
D
2023-01-06
Common Stock
33011
30511
D
The option, representing a right to purchase a total of 10,305 shares, is fully-vested and exercisable for 100% of the underlying shares.
The option, representing a right to purchase a total of 35,511 shares, vests in equal monthly installments over four years, resulting in the option becoming exercisable for 100% of the underlying shares on the fourth anniversary of the date of grant.
/s/ Hemmie Chang, attorney-in-fact for Jeffrey D. Chulay
2015-08-14